Literature DB >> 31715371

CA8 promotes RCC proliferation and migration though its expression level is lower in tumor compared to adjacent normal tissue.

Huai-Lu Ma1, Sheng-Jian Yu2, Jie Chen3, Xiao-Fei Ding3, Guang Chen4, Yong Liang5, Jian-Li Pan6.   

Abstract

Chemotherapy and radiotherapy are not as successful in the case of renal cell carcinoma (RCC) although some targeted drugs were approved for RCC therapy recently. Analysis of whole genomic data will lead to improvements in understanding RCC and identifying novel anticancer targets. Here, we found the differential mRNA expression and copy number variation (CNV) of Carbonic anhydrase-related protein VIII (CA8) gene in RCC through integrated bioinformatics analysis of TCGA database, which was confirmed in 5 cases of samples collected from RCC patients who underwent radical nephrectomy by analysis of CA8 mRNA and protein levels using RT-PCR immunohistochemical assay. However, we got a completely opposite result that CA8 promoted RCC progression, those are CA8 overexpression promoted the proliferative and migratory ability of Caki-1 and 769-P cells in vitro as determined with MTT and transwell assay, and CA8 overexpression could also promote Caki-1 xenograft growth in BALB/C‑nu/nu mice. On the contrary, CA8-knockdown reduced Caki-1 and 769-P cell proliferation and migration. Moreover, knockdown of CA8 decreased pAKT and MMP2 protein levels in Caki-1 cells while overexpressing CA8 increased pAKT and MMP2. In conclusion, we showed that CA8 promoted RCC cell proliferation and migration, but it was down-regulated in RCC, which requires an additional mechanism study.
Copyright © 2019 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Carbonic anhydrase 8; Cell migration; Proliferation; Renal clear carcinoma

Mesh:

Substances:

Year:  2019        PMID: 31715371     DOI: 10.1016/j.biopha.2019.109578

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   7.419


  6 in total

1.  RB1CC1 functions as a tumor-suppressing gene in renal cell carcinoma via suppression of PYK2 activity and disruption of TAZ-mediated PDL1 transcription activation.

Authors:  Pingfeng Chen; Youjun Duan; Xinsheng Lu; Libo Chen; Wang Zhang; Hao Wang; Rong Hu; Shimin Liu
Journal:  Cancer Immunol Immunother       Date:  2021-04-10       Impact factor: 6.968

2.  Carbonic Anhydrase VIII (CAVIII) Gene Mediated Colorectal Cancer Growth and Angiogenesis through Mediated miRNA 16-5p.

Authors:  Mingli Hsieh; Pei-Ju Huang; Pei-Yu Chou; Shih-Wei Wang; Hsi-Chi Lu; Wei-Wen Su; Yuan-Chiang Chung; Min-Huan Wu
Journal:  Biomedicines       Date:  2022-04-29

3.  Keratin 17 Suppresses Cell Proliferation and Epithelial-Mesenchymal Transition in Pancreatic Cancer.

Authors:  Yong Zeng; Min Zou; Yan Liu; Keting Que; Yunbing Wang; Changan Liu; Jianpin Gong; Yu You
Journal:  Front Med (Lausanne)       Date:  2020-11-26

4.  Inhibition of FSTL3 abates the proliferation and metastasis of renal cell carcinoma via the GSK-3β/β-catenin signaling pathway.

Authors:  Fengfeng Sun; Peng Sun; Xiaofeng Yang; Liangliang Hu; Jianguo Gao; Tao Tian
Journal:  Aging (Albany NY)       Date:  2021-09-23       Impact factor: 5.682

5.  Mxi1 participates in the progression of lung cancer via the microRNA-300/KLF9/GADD34 Axis.

Authors:  Yujie Lei; Yunchao Huang; Jianbin Lin; Shihui Sun; Keda Che; Junting Shen; Jun Liao; Yangming Chen; Kai Chen; Zhaoxian Lin; Xing Lin
Journal:  Cell Death Dis       Date:  2022-05-02       Impact factor: 8.469

6.  WISP1 induces ovarian cancer via the IGF1/αvβ3/Wnt axis.

Authors:  Yan Li; Fangfang Wang; Tianyi Liu; Nan Lv; Xiaolei Yuan; Peiling Li
Journal:  J Ovarian Res       Date:  2022-08-13       Impact factor: 5.506

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.